| Translated title of the contribution | No evidence of safety concerns other than the known side effects: Tocilizumab seems safe to use in COVID-19 |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 22-24 |
| Number of pages | 3 |
| Journal | Pharmaceutisch Weekblad |
| Volume | 156 |
| Issue number | 23 |
| Publication status | Published - 11 Jun 2021 |
Tocilizumab lijkt veilig toepasbaar bij COVID-19
Fenna Poppelaars, Jette van Lint, Harald Vonkeman, Heieen van der Sijs, Juliëtte Zwaveling, Marjolein Drent, Marieke Kerskes, Arthur van Zanten, Naomi Jessurun
Research output: Contribution to journal › Article › Academic › peer-review